Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Nanotechnology has been extensively studied and exploited for cancer treatment as nanoparticles can play a significant role as a drug delivery system. Compared to conventional drugs, nanoparticle-based drug delivery has specific advantages, such as improved stability and biocompatibility, enhanced p...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmolb.2020.00193/full |
id |
doaj-72a6720bc25d48e2b4cb0451d3b1f11f |
---|---|
record_format |
Article |
spelling |
doaj-72a6720bc25d48e2b4cb0451d3b1f11f2020-11-25T03:38:39ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2020-08-01710.3389/fmolb.2020.00193558493Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug ResistanceYihan Yao0Yunxiang Zhou1Lihong Liu2Yanyan Xu3Yanyan Xu4Qiang Chen5Yali Wang6Shijie Wu7Yongchuan Deng8Jianmin Zhang9Anwen Shao10Department of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Radiation Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaSchool of Pharmacy, Nanjing Medical University, Nanjing, ChinaKey Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaCancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Surgical Oncology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaNanotechnology has been extensively studied and exploited for cancer treatment as nanoparticles can play a significant role as a drug delivery system. Compared to conventional drugs, nanoparticle-based drug delivery has specific advantages, such as improved stability and biocompatibility, enhanced permeability and retention effect, and precise targeting. The application and development of hybrid nanoparticles, which incorporates the combined properties of different nanoparticles, has led this type of drug-carrier system to the next level. In addition, nanoparticle-based drug delivery systems have been shown to play a role in overcoming cancer-related drug resistance. The mechanisms of cancer drug resistance include overexpression of drug efflux transporters, defective apoptotic pathways, and hypoxic environment. Nanoparticles targeting these mechanisms can lead to an improvement in the reversal of multidrug resistance. Furthermore, as more tumor drug resistance mechanisms are revealed, nanoparticles are increasingly being developed to target these mechanisms. Moreover, scientists have recently started to investigate the role of nanoparticles in immunotherapy, which plays a more important role in cancer treatment. In this review, we discuss the roles of nanoparticles and hybrid nanoparticles for drug delivery in chemotherapy, targeted therapy, and immunotherapy and describe the targeting mechanism of nanoparticle-based drug delivery as well as its function on reversing drug resistance.https://www.frontiersin.org/article/10.3389/fmolb.2020.00193/fullnanoparticledrug deliveryhybrid nanoparticlestargeted cancer therapydrug resistance |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yihan Yao Yunxiang Zhou Lihong Liu Yanyan Xu Yanyan Xu Qiang Chen Yali Wang Shijie Wu Yongchuan Deng Jianmin Zhang Anwen Shao |
spellingShingle |
Yihan Yao Yunxiang Zhou Lihong Liu Yanyan Xu Yanyan Xu Qiang Chen Yali Wang Shijie Wu Yongchuan Deng Jianmin Zhang Anwen Shao Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance Frontiers in Molecular Biosciences nanoparticle drug delivery hybrid nanoparticles targeted cancer therapy drug resistance |
author_facet |
Yihan Yao Yunxiang Zhou Lihong Liu Yanyan Xu Yanyan Xu Qiang Chen Yali Wang Shijie Wu Yongchuan Deng Jianmin Zhang Anwen Shao |
author_sort |
Yihan Yao |
title |
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance |
title_short |
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance |
title_full |
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance |
title_fullStr |
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance |
title_full_unstemmed |
Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance |
title_sort |
nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Molecular Biosciences |
issn |
2296-889X |
publishDate |
2020-08-01 |
description |
Nanotechnology has been extensively studied and exploited for cancer treatment as nanoparticles can play a significant role as a drug delivery system. Compared to conventional drugs, nanoparticle-based drug delivery has specific advantages, such as improved stability and biocompatibility, enhanced permeability and retention effect, and precise targeting. The application and development of hybrid nanoparticles, which incorporates the combined properties of different nanoparticles, has led this type of drug-carrier system to the next level. In addition, nanoparticle-based drug delivery systems have been shown to play a role in overcoming cancer-related drug resistance. The mechanisms of cancer drug resistance include overexpression of drug efflux transporters, defective apoptotic pathways, and hypoxic environment. Nanoparticles targeting these mechanisms can lead to an improvement in the reversal of multidrug resistance. Furthermore, as more tumor drug resistance mechanisms are revealed, nanoparticles are increasingly being developed to target these mechanisms. Moreover, scientists have recently started to investigate the role of nanoparticles in immunotherapy, which plays a more important role in cancer treatment. In this review, we discuss the roles of nanoparticles and hybrid nanoparticles for drug delivery in chemotherapy, targeted therapy, and immunotherapy and describe the targeting mechanism of nanoparticle-based drug delivery as well as its function on reversing drug resistance. |
topic |
nanoparticle drug delivery hybrid nanoparticles targeted cancer therapy drug resistance |
url |
https://www.frontiersin.org/article/10.3389/fmolb.2020.00193/full |
work_keys_str_mv |
AT yihanyao nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance AT yunxiangzhou nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance AT lihongliu nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance AT yanyanxu nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance AT yanyanxu nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance AT qiangchen nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance AT yaliwang nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance AT shijiewu nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance AT yongchuandeng nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance AT jianminzhang nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance AT anwenshao nanoparticlebaseddrugdeliveryincancertherapyanditsroleinovercomingdrugresistance |
_version_ |
1724541275505426432 |